Hillsdale Investment Management Inc. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$963,000
+28.4%
56,600
-64.5%
0.09%
+23.0%
Q3 2020$750,000
+0.8%
159,600
+30.9%
0.07%
+8.8%
Q2 2020$744,000121,9000.07%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders